Founded in 2005, Korea Institute for Pharmaceutical Policy Affairs, KIPPA, is a non-profit, public foundation, approved by the Korean Ministry of Health and Welfare. The institute is contributed by three relevant parties, the Korean Pharmaceutical Association (KPA), the Korea Pharmaceutical and Bio-Pharma Manufacturers Association (KBPMA), and the Korea Pharmaceutical Distribution Association (KPDA).

KIPPA is a leading research center, which aims to promote public health through the development of policy regarding the rational use of medicines, pharmacy education, pharmacy practice, pharmaceutical industry, and pharmaceutical supply and distribution. In particular, we begin to develop ¡®a community pharmacy model as a health promotion center for community members¡¯. We are collecting and analysing big data accordingly to develop pharmacy-based policies, which pursue maximised pharmacy practice for all the Koreans.

In consequence, KIPPA will consistently implement research tailored to the promotion of health in the nation and worldwide. We kindly ask for supports from our fellow pharmacists, public and associations.

If you have any further enquiries about the institute or research in English, please contact us via e-mail (kippa.org@gmail.com).

Thank you.

Office Address
3FL, 194, Hyoryeong-ro, Seocho-gu, Seoul, Repbulic of Korea

ÇöÀçÀ§Ä¡ : Home : ¾Ë¸²¸¶´ç : ¿¬±¸¼Ò ´º½º
   
¾Ë¸²¸¶´ç
°øÁö»çÇ×
º¸µµÀÚ·á
ÀÎÀçä¿ë
 
 
Á¦   ¸ñ [´ëÇѾà»çÀú³Î] Áö¿ª¾à±¹ '»ý¸íÁöÅ´ÀÌ' ¿ªÇÒ ¼öÇà °ü½É ³ôÇû´Ù
³»   ¿ë

Áö¿ª¾à±¹ '»ý¸íÁöÅ´ÀÌ' ¿ªÇÒ ¼öÇà °ü½É ³ôÇû´Ù

Áö¿ª¿¬°è °­È­¸¦ ÅëÇÑ ¾à±¹ Àڻ쿹¹æ¿ªÇÒ °­È­ <4>


»ç¾÷ Ã¥ÀÓÀÚ ¹ÚÇý°æ ÀǾàǰÁ¤Ã¥¿¬±¸¼ÒÀå
Âü¿© ¿¬±¸¿ø ±èÁøÀ̠åÀÓ¿¬±¸¿ø / È«¼ºÇö ºÎ¿¬±¸À§¿ø
ÆíÁý ÀÓÀ翵 ½ÇÀå / ÀÌÁÖÇϠåÀÓ¿¬±¸¿ø

´ëÇѾà»çȸ¿Í ÀǾàǰÁ¤Ã¥¿¬±¸¼Ò´Â º¸°Çº¹ÁöºÎ °úÁ¦·Î 2020³â Àڻ쿹¹æ»ç¾÷À» ÁøÇàÇßÀ¸¸ç, À̴ 2017³â°ú 2018³â¿¡ À̾¼ ¹øÂ°·Î ÁøÇàµÈ »ç¾÷ÀÌ´Ù. 

Áö¿ª¾à±¹ ¹× ¾à»ç¸¦ ÅëÇÑ Àڻ쿹¹æ»ç¾÷ÀÇ È¿°ú¿¡ ´ëÇÑ ±âÁ¸ ¼±Çà ¿¬±¸µé°ú ÇÔ²² ºÎ»ê ¼­±¸ Á¤½Å°Ç°­º¹Áö¼¾ÅÍ¿¡¼­ ÁøÇàµÈ Á¶»ç °á°ú¿¡ µû¸£¸é, »ý¸íÁ¸Áß ¾à±¹ ¹æ¹® °ËÁø¿¡¼­ ¹ß±¼µÈ ¿ì¿ï °íÀ§Ç豺 ºñÀ²(25.8%)ÀÌ ºÎ»ê ÁöÇÏö Ä·ÆäÀο¡¼­ ¹ß±¼µÈ ¿ì¿ï °íÀ§Ç豺 ºñÀ²(17%)º¸´Ù ³ôÀº °ÍÀ¸·Î ³ªÅ¸³µ´Ù. ¶ÇÇÑ, Àڻ젰íÀ§Ç豺 ¹ß±¼ ºñÀ²¿¡¼­µµ Áö¿ªÇà»ç Ä·ÆäÀÎÀÌ 12.9%, ¾à±¹ ¹æ¹®°ËÁøÀÌ 19.8%·Î ³ªÅ¸³ª ÁöÇÏöÀ̳ª Áö¿ªÇà»ç Ä·ÆäÀκ¸´Ù ¾à±¹¿¡¼­ ÁøÇàÇϴ ¹æ¹® °ËÁøÀÌ Á¤½Å °Ç°­ ¹× Àڻ젰íÀ§Ç豺À» ¹ß±¼Çϴµ¥ È¿°úÀûÀ̶ó´Â »ç½ÇÀ» º¸°íÇß´Ù.

Áö¿ª¾à±¹Àº ÀϹÝÀεéÀÇ ½É¸®Àû, ¹°¸®ÀûÀΠÁ¢±Ù¼ºÀÌ ³ô°í ¾à»ç¿Í ½É¸®ÀûÀ¸·Î Æí¾ÈÇϰԠ´ëÈ­¸¦ ³ª´­ ¼ö Àִٴ Á¡¿¡¼­ ÀÚ»ìÀ§Çè Á¶±â¹ß°ßÀ» À§ÇÑ ÃÖÀûÀÇ ±¸½ÉÁ¡ÀÌ µÉ ¼ö ÀÖ´Ù. µû¶ó¼­, 2020³â Àڻ쿹¹æ»ç¾÷Àº ¾à»ç ´ë»ó »ý¸íÁöÅ´ÀÌ ¾ç¼º ¹× º¹¾àÁöµµ Á¦°í¸¦ ÅëÇØ Áö¿ª¾à±¹°ú Áö¿ªÀڻ쿹¹æ¼¾ÅÍ(Á¤½Å°Ç°­º¹Áö¼¾ÅÍ)¿ÍÀÇ ÇùÁ¶Ã¼°è¸¦ ±¸ÃàÇÏ¿© ´ëÇѹα¹ÀÇ ÀÚ»ìÀ§ÇèÀ» ³·Ãߴµ¥ ±â¿©ÇϰíÀÚ Çϴ¸ñÇ¥¸¦ °®°í ¼öÇàµÇ¾úÀ¸¸ç, º» ±Û¿¡¼­´Â 2020³â¿¡ ¼öÇàÇß´ø Áö¿ª¾à±¹ÀÇ Àڻ젿¹¹æ»ç¾÷ ³»¿ë°ú °á°ú¸¦ ¼Ò°³ÇϰíÀÚ ÇÑ´Ù.


<Áö³­È£¿¡ À̾>
¥±. »ç¾÷ÀÇ ³»¿ë ¹× °á°ú


3. ±â È°µ¿ ¾à»çµéÀ» Áß½ÉÀ¸·Î ¿ì¼ö»ç·ÊÁý ¹ß°£
(1) »ç¾÷ ³»¿ë
¾à»ç°ø·Ð°ú ÇÔ²² ±â È°µ¿¾à»çµéÀÇ »ý¸íÁöÅ´ÀÌ ¼ö±â»ç·Ê °ø¸ðÀüÀ» ÁøÇàÇßÀ¸¸ç(2020. 7.~2020. 11.) °ø¸ðµÈ ¼ö±â»ç·Ê¸¦ °ËÅäÇϰí Áß¾ÓÀڻ쿹¹æ¼¾ÅÍÀÇ ÀÚ¹®À» ¹Þ¾Æ Áö¿ª¾à±¹ÀÇ »ý¸íÁöÅ´ÀÌÀÇ ¿ªÇÒÀÌ Àß µå·¯³­ »ç·Ê¸¦ ¼±Á¤Çì ¼ö±â»ç·ÊÁýÀ» Á¦ÀÛÇß´Ù. 

¼ö±â»ç·ÊÁý¿¡´Â 7°³ÀÇ ¼ö±â»ç·Ê¿Í 7°³ÀÇ ¾à»çµéÀÇ »ý¸íÁöÅ´ÀÌ¿¡ ´ëÇÑ »ý°¢ÀÌ ´ã°ÜÀÖ´Ù.

(2) »ç¾÷ °á°ú
»ý¸íÁöÅ´ÀÌ ±³À°À» À̼öÇÑ ¾à»ç Áß ½ÅûÀÚ¿¡°Ô »ç·ÊÁýÀ» ¹èÆ÷ÇØ ¾à±¹¿¡¼­ÀÇ »ý¸íÁöÅ´ÀÌ »ç·ÊµéÀ» °øÀ¯Çß´Ù.

4. Àڻ쿹¹æ »ý¸íÁöÅ´ÀÌ ¸Å´º¾ó °³¹ß
(1) »ç¾÷ ³»¿ë
¾à»ç ´ë»ó Àڻ쿹¹æ ¿¬¼ö±³À° Ã¼°è ¹× ÇÁ·Î±×·¥, Áö¿ª¾à±¹ÀÇ ¿ì¿ïÁõ È¯ÀÚ ´ë»ó º¹¾àÁöµµ»ç·Ê ¹× ¿ì¿ïÁõ È¯ÀÚÀÇ º¹¾à¼øÀÀµµ Çâ»óÀ» À§ÇÑ ¾à·á¼­ºñ½º °ü·Ã ÀÚ·áÁ¶»ç¸¦ ÅëÇØ ¸Å´º¾óÀ» Á¦ÀÛÇß´Ù. 


±¤¿ªÁ¤½Å°Ç°­º¹Áö¼¾ÅÍÀÇ »ý¾ÖÁֱ⺰ Àڻ쿹¹æ ±³À°(Çлý, Á÷ÀåÀÎ, ³ëÀεî) ¸Å´º¾ó, »ý¸íÁ¸Á߸Ŵº¾ó, ÀÚ»ìÀ§±â°³ÀÔÇÚµåºÏ, Àڻ젹נÁ¤½ÅÁúȯ À§±â°ü¸® ÇÁ·ÎÅäÄÝ, Àڻ캸µµ ±Ç°í±âÁØ 2.012) µîÀÇ º¸°Çº¹ÁöºÎ ÀÎÁõÇÁ·Î±×·¥°ú, ±¹³»¿Ü ¿ì¿ïÁõ È¯ÀÚ º¹¾àÁöµµÀÇ ¾Ë°í¸®Áò ¹× Ç¥ÁØÈ­ ÁöħÀ» Á¶»çÇßÀ¸¸ç, ¾àÇаè¿Í »ý¸íÁöÅ´À̠Ȱµ¿ ¾à»ç ´ë»óÀ¸·Î ÀÚ¹®¹Þ¾Æ ¸Å´º¾óÀ» ¼öÁ¤Çß´Ù.

(2) »ç¾÷ °á°ú
»ý¸íÁöÅ´À̷μ­ ¸ð´ÏÅ͸µ ¹× ¿¬°è¸¦ À§ÇØ Á¦À۵Ƞ¸Å´º¾ó¿¡ Æ÷ÇԵȠ³»¿ëÀº ¸ð´ÏÅ͸µ ¹× Àü¹®±â°ü ¿¬°è¸¦ À§ÇÑ ¸Å´º¾ó°ú °íÀ§Çè È¯ÀÚ »ó´ãÀ» À§ÇÑ ±âÃÊÁö½Ä¿¡ ´ëÇÑ ³»¿ëÀÌ´Ù.

¥². ³ª°¡¸ç
2020³â Áö¿ª¾à±¹À» ÅëÇÑ Àڻ쿹¹æ»ç¾÷Àº Áö¿ª¾à±¹ÀÇ ¶ß°Å¿î °ü½É°ú Âü¿©·Î µ¿ »ç¾÷ÀÇ 8°³ Ç׸ñ ¸ñÇ¥º° ÃßÁø½ÇÀûÀ» ¸ðµÎ 100% ÀÌ»ó ´Þ¼ºÇÏ¿´´Ù. Áï Áö¿ª Á¤½Å°Ç°­º¸°Ç¼¾ÅÍ¿ÍÀÇ ¾÷¹«Çù¾à µ¶·Á ¹× Ã¼°á ´Þ¼ºµµ°¡ °¢°¢ 200%, 100%¿´À¸¸ç, »ý¸íÁöÅ´ÀÌ ±³À°Àº 133% ´Þ¼ºÇß´Ù. 

±× ¿Ü »ý¸íÁöÅ´ÀÌ ¸Å´º¾ó, ¼ö±â»ç·ÊÁý, ¾à±¹¿¡¼­ È°¿ëÇÒ ¼ö Àִ »ý¸íÁöÅ´ÀÌ ½ºÆ¼Ä¿, ¸®Ç÷¿ÀÇ Á¦ÀÛ¡¤¹èÆ÷»ç¾÷ ¸ðµÎÀÇ ¸ñÇ¥¸¦ 100% ´Þ¼ºÇß´Ù.

Àüü »ç¾÷Àº ´ëÇѾà»çȸ ÁÖ°üÇÏ¿¡ »êÇÏ ¹× À¯°ü ±â°üÀÌ Çù·ÂÇÏ¿© ÁøÇàÇØ »ç¾÷ÀÇ ½Ã³ÊÁö È¿°ú¸¦ Ã¢ÃâÇß´Ù. ´ëÇѾà»çȸ°¡ »ç¾÷ Àü¹ÝÀ» ÃѰýÇß°í ÁöºÎ¡¤ºÐȸ·ÎÀÇ Àü´Þ ¿ªÇÒÀ» ´ã´çÇßÀ¸¸ç, ÀǾàǰÁ¤Ã¥¿¬±¸¼Ò°¡ ÄÜÅÙÃ÷ ±âȹ ¹× Á¦ÀÛ ¾÷¹«¸¦ ¼öÇàÇßÀ¸¸ç, »çÀ̹ö¿¬¼ö¿ø ¹× ¾àÇÐÁ¤º¸¿øÀÌ ¿¬¼ö±³À° °ü·Ã ¾÷¹«¸¦ ¼öÇàÇß°í, ¾à»ç°ø·ÐÀÌ ÄÜÅÙÃ÷ÀÇ µðÀÚÀΠ°³¹ß ¹× Áö¼ÓÀûÀΠȫº¸¸¦ ÁøÇàÇß´Ù.

±×·±µ¥, µ¿ »ç¾÷ÀÇ ´Þ¼ºµµ ¹× À¯°ü ±â°ü °£ Çù·ÂÀû »ç¾÷À¸·ÎÀÇ ÁøÇà°úÁ¤º¸´Ù ´õ¿í Àǹ̠ÀÖ¾ú´ø °á°ú´Â, ÀÌ »ç¾÷À» ÅëÇØ Áö¿ª¾à±¹ÀÌ »ý¸íÁöÅ´À̷μ­ÀÇ ¿ªÇÒ ¹× Ã¥ÀÓ°¨¿¡ ´ëÇØ °ü½ÉÀ» °¡Áö°í °í¹ÎÇϱ⠽ÃÀÛÇߴٴ °ÍÀ̸砽ÇÁ¦ ±× ¿ªÇÒÀ» ½ÇõÇÏ·Á°í ³ë·ÂÇߴٴ °ÍÀÌ´Ù. 

¶ÇÇÑ À̹̠Áö¿ª¾à±¹¿¡ ±Ù¹«Çϴ ¸¹Àº ¾à»çµéÀÌ Åõ¾à ¹× º¹¾àÁöµµ °úÁ¤¿¡¼­ »ý¸íÁöÅ´ÀÌÀÇ ¿ªÇÒÀ» ¼öÇàÇϰí ÀÖ¾úÀ¸¸ç ÀÌ¿¡ ÇÊ¿äÇÑ ÇнÀ ¹× È¯ÀÚ¸¦ ´ë»óÀ¸·Î ÇÑ ´ëÈ­ÀÇ ±â¼ú¿¡ ´ëÇØ °ü½ÉÀÌ ¸¹¾Ò´Ù´Â °ÍÀ» È®ÀÎÇÑ °ÍÀÌ´Ù. 

µû¶ó¼­, ÃßÈÄ ¾à»ç¸¦ ´ë»óÀ¸·Î »ý¸íÁöÅ´À̷μ­ÀÇ ¿ªÇÒ ¼öÇàÀ» À§ÇØ ÇÊ¿äÇÑ Áö¼ÓÀûÀΠ±³À°ÀÌ ÇÊ¿äÇÒ °ÍÀ¸·Î »ý°¢µÈ´Ù. ÀÌ·¯ÇÑ ¸Æ¶ô¿¡¼­ ¾à»ç ´ë»ó ±³À°ÀÚ·á ¹× ¾à±¹¿¡¼­ ´Ù¾çÇÑ »ç¶÷µé°ú ¼ÒÅë ¹× »ó´ãÇϴ ±â¼ú¿¡ ´ëÇÑ ±³À°ÀÚ·á Á¦ÀÛ ¹× À̵é ÀÚ·á¿¡ ´ëÇÑ ±³À°ÀÌ ÇÊ¿äÇÒ °ÍÀ¸·Î »ý°¢µÈ´Ù.


[±â»çÃâó] https://www.kpanews.co.kr/academy/show.asp?page=1&search_cate=8&idx=641

 

¹øÈ£ ÷ºÎ Á¦¸ñ ÀÛ¼ºÀÚ ÀÛ¼ºÀÏ Á¶È¸
129 [´ëÇѾà»çÀú³Î]°ø°ø½É¾ß¾à±¹, »ç¾÷ È®´ë À§ÇØ ¿î¿µ¡¤ÆíÀÇ °³¼± ÇÊ¿ä ÀÌÁÖÇÏ 2021-09-23 898
128 [´ëÇѾà»çÀú³Î]½É¾ß½Ã°£ ¾à±¹ ÀÌ¿ë '¸¸Á·ÇÑ´Ù' 93.5% ÀÌÁÖÇÏ 2021-09-23 777
127 [´ëÇѾà»çÀú³Î]¿µ±¹, OHH ¼­ºñ½º ÀϹݾࡤÀü¹®¾à ³ª´² Á¦°ø ÀÌÁÖÇÏ 2021-09-23 755
126 [´ëÇѾà»çÀú³Î]È£ÁÖ ¹ãÀ» ¹àÈ÷´Â 'Supercare' ¾à±¹ ÀÌÁÖÇÏ 2021-09-23 762
125 [ÀǾàǰÁ¤Ã¥¸®Æ÷Æ®]ÀÀ´äÀÚ 94.3% µµÀÔ Âù¼º¡¦Àü¹®Àû »ó´ã Àý½Ç ÀÌÁÖÇÏ 2021-09-23 249
124 [´ëÇѾà»çÀú³Î] ¾à ±¸ÀÔ ½Ã ¾à»ç¿Í »ó´ãÀÌ Áß¿ä 85% ÀÌÁö¿¬ 2021-08-10 519
123 [´ëÇѾà»çÀú³Î] ÀǾàǰ ¾ÈÀü»ç¿ë ±³À° 'µµ¿òµÆ´Ù' 98% ÀÌÁö¿¬ 2021-08-02 458
122 [´ëÇѾà»çÀú³Î] ¾ÆÆí ÇÔÀ¯ 'Á¤ÅëÆí' ÅëÁõ ¸¸º´ÅëÄ¡¾àó·³ »ç¿ë ÀÌÁö¿¬ 2021-08-02 506
121 [´ëÇѾà»çÀú³Î] ºÏÇÑÀÌÅ»ÁֹΠó¹æÀǾàǰ È¿°ú ½Å·Ú ´õ ³ô¾Æ ÀÌÁö¿¬ 2021-07-21 448
120 [´ëÇѾà»çÀú³Î] ºÏÇÑÀÌÅ»ÁֹΠÀǾàǰ Àνİú »ç¿ë ÇöȲÀº? ÀÌÁö¿¬ 2021-07-14 390
119 [´ëÇѾà»çÀú³Î] "ºÎÀÛ¿ë °æÇè 98% Áõ»ó ½Å°í¾ÈÇØ" ºÒ°¨Áõ ½É°¢ ÀÌÁö¿¬ 2021-07-07 464
118 [´ëÇѾà»çÀú³Î] ¾ÈÀü»óºñÀǾàǰ ±¸ÀÔ ¿äÀÏ ÁÖ¸» '50.3%' Â÷Áö ÀÌÁö¿¬ 2021-06-29 452
117 [´ëÇѾà»çÀú³Î] ±¹¹Î 90% 1³â°£ ÆíÀÇÁ¡ »óºñ¾à ÃÖ´ë 5ȸ ±¸ÀÔ ÀÌÁö¿¬ 2021-06-22 485
116 [´ëÇѾà»çÀú³Î] ÆíÀÇÁ¡ ºøÀå Ç®¸®ÀÚ ½ñ¾ÆÁø °¨±â¾à¡¤ÁøÅëÁ¦ ÀÌÁö¿¬ 2021-06-16 432
115 [´ëÇѾà»çÀú³Î] Áö¿ª¾à±¹ '»ý¸íÁöÅ´ÀÌ' ¿ªÇÒ ¼öÇà °ü½É ³ôÇû´Ù ÀÌÁö¿¬ 2021-06-09 441

ÀÌÀü 10ÆäÀÌÁö [1]  [2]  [3]  [4]  [5]  [6]  [7]  [8]  [9]  ´ÙÀ½ 10ÆäÀÌÁö

 
 

¼­¿ï ¼­Ãʱ¸ È¿·É·Î194, 3Ãþ (Àç)ÀǾàǰÁ¤Ã¥¿¬±¸¼Ò TEL : 02) 3474-5301 / FAX : 02)3474-5306

COPYRIGHT (C) 2006 KOREA INSTITUTE FOR PHARMACEUTICAL POLICY AFFAIRS ALL RIGHTS RESERVED. FOR MORE INFORMATION MAL kippa.org@gmail.com

±âºÎ±Ý ¾È³»